United Arab Emirates: Medicaments Containing Insulin Market 2024

Medicaments Containing Insulin Market Size in the United Arab Emirates

In 2021, the medicaments containing insulin market in the United Arab Emirates was finally on the rise to reach $X for the first time since 2018, thus ending a two-year declining trend. Overall, consumption showed prominent growth. Over the period under review, the market attained the maximum level at $X in 2018; however, from 2019 to 2021, consumption failed to regain momentum.

Medicaments Containing Insulin Production in the United Arab Emirates

In value terms, medicaments containing insulin production reached $X in 2021 estimated in export price. Overall, production, however, showed a slight decline. The growth pace was the most rapid in 2013 when the production volume increased by 21% against the previous year. As a result, production reached the peak level of $X. From 2014 to 2021, production growth remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the United Arab Emirates

In 2021, approx. X tons of medicaments containing insulin but not antibiotics were exported from the United Arab Emirates; which is down by -45.4% compared with the previous year's figure. Over the period under review, exports showed a deep setback. The pace of growth appeared the most rapid in 2020 with an increase of 1,564%. The exports peaked at X tons in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

In value terms, medicaments containing insulin exports shrank sharply to $X in 2021. In general, exports recorded a abrupt decline. The most prominent rate of growth was recorded in 2020 when exports increased by 938%. Over the period under review, the exports attained the maximum at $X in 2012; however, from 2013 to 2021, the exports stood at a somewhat lower figure.

Exports by Country

Sudan (X tons) was the main destination for medicaments containing insulin exports from the United Arab Emirates, accounting for a 91% share of total exports. Moreover, medicaments containing insulin exports to Sudan exceeded the volume sent to the second major destination, Oman (X kg), tenfold.

From 2012 to 2021, the average annual rate of growth in terms of volume to Sudan amounted to +16.2%. Exports to the other major destinations recorded the following average annual rates of exports growth: Oman (-15.0% per year) and Nigeria (-53.2% per year).

In value terms, Sudan ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from the United Arab Emirates, comprising 92% of total exports. The second position in the ranking was taken by Oman ($X), with a 5.5% share of total exports.

From 2012 to 2021, the average annual rate of growth in terms of value to Sudan totaled +23.3%. Exports to the other major destinations recorded the following average annual rates of exports growth: Oman (-18.7% per year) and Nigeria (-47.0% per year).

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2021, jumping by 25% against the previous year. In general, the export price, however, faced a deep downturn. The most prominent rate of growth was recorded in 2016 an increase of 119% against the previous year. Over the period under review, the average export prices reached the maximum at $X per ton in 2013; however, from 2014 to 2021, the export prices stood at a somewhat lower figure.

There were significant differences in the average prices for the major external markets. In 2021, amid the top suppliers, the country with the highest price was Nigeria ($X per ton), while the average price for exports to Oman ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was recorded for supplies to Nigeria (+12.6%), while the prices for the other major destinations experienced mixed trend patterns.

Medicaments Containing Insulin Imports

Imports into the United Arab Emirates

In 2021, after two years of decline, there was significant growth in overseas purchases of medicaments containing insulin but not antibiotics, when their volume increased by 17% to X kg. In general, imports, however, continue to indicate a abrupt shrinkage. The pace of growth was the most pronounced in 2014 when imports increased by 553%. As a result, imports reached the peak of X kg. From 2015 to 2021, the growth of imports remained at a somewhat lower figure.

In value terms, medicaments containing insulin imports expanded remarkably to $X in 2021. Overall, imports showed noticeable growth. The most prominent rate of growth was recorded in 2016 with an increase of 137% against the previous year. Over the period under review, imports reached the peak figure at $X in 2018; however, from 2019 to 2021, imports remained at a lower figure.

Imports by Country

In 2021, France (X kg) constituted the largest medicaments containing insulin supplier to the United Arab Emirates, accounting for a 81% share of total imports. Moreover, medicaments containing insulin imports from France exceeded the figures recorded by the second-largest supplier, the UK (X kg), ninefold. The third position in this ranking was taken by the United States (X kg), with a 4.8% share.

From 2012 to 2021, the average annual growth rate of volume from France stood at +10.4%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (-7.4% per year) and the United States (-7.4% per year).

In value terms, Germany ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the United Arab Emirates, comprising 56% of total imports. The second position in the ranking was taken by France ($X), with a 21% share of total imports. It was followed by the United States, with an 11% share.

From 2012 to 2021, the average annual rate of growth in terms of value from Germany totaled +5.4%. The remaining supplying countries recorded the following average annual rates of imports growth: France (+18.2% per year) and the United States (+5.4% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2021, declining by -3.4% against the previous year. Over the period under review, the import price, however, showed a buoyant increase. The growth pace was the most rapid in 2015 an increase of 160% against the previous year. The import price peaked at $X per ton in 2017; however, from 2018 to 2021, import prices failed to regain momentum.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Germany ($X per ton), while the price for France ($X per ton) was amongst the lowest.

From 2012 to 2021, the most notable rate of growth in terms of prices was attained by Germany (+40.9%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :